 |
3rd Thursday Community Engagement Education Series
Advancing Community-Engaged Research Approaches Through Education
and Networking
|
Session 2: Creating and Nurturing Community Advisory Boards
Feb. 18, 2021, 12:00 – 1:00 p.m.
|
The BU CTSI CE Program Monthly Education Series will provide education on community-engaged research approaches and promote networking among BU colleagues who are actively engaging communities in the research process.
|
|
|
|
|
9th Annual CTSI Translational Science Symposium
In Memory of David Seldin, MD, PhD (1957-2015)
|
Race & Research: Old Challenges, New Approaches
Feb. 24, 2021, 8 a.m. - 1 p.m.
Society is increasingly seeking answers about the role and impact that racism and structural oppression play in every facet of medical research conducted in the US. This year, the CTSI has chosen to fashion our 2021 CTSI Symposium as a fresh opportunity for the BUMC/BMC/BU research community to ponder these questions, challenges, and the difficult decisions associated with this focus. We will discuss novel approaches to provide better designed anti-racist research. You will learn from fellow researchers who have thoughtfully and rigorously applied anti-racist principles to engage in clinical and translational medical research. Our symposium has been designed to provide a safe, opportunity for you to think deeper about these essential issues and to challenge yourself to participate with your peers and colleagues in an open, honest and non-judgmental but challenging dialogue about race and research. We sincerely hope you can join us! Visit Our Webpage
View the Draft Symposium Agenda Here.
|
The KL2 program is a mentored career development program for BU's most promising junior faculty translational researchers. This program is committed to increasing the diversity of the research workforce and strongly encourages applications from underrepresented, racial, and ethnic groups (UREGs). Read More
|
Presented at 12 p.m. by: William G. Adams, MD, Kimberly Ann Dukes, PhD, & Heather Hsu, MD, MPH. This 2nd presentation focuses on the "Use of Large Data Sets to Facilitate Research with Underrepresented Groups", which is built upon earlier presentations on research regulatory considerations related to vulnerable subjects. Read More
|
An interactive training program that uses case studies developed and vetted with other Clinical & Translational Science Institutes around the country. This is a great opportunity to interact with and learn from colleagues in other disciplines. A certificate will be supplied to include in your training grant applications. Read More
|
We are delighted to announce that the BU CTSI will support two post-Doctoral fellows as part of the CTSI training program in regenerative medicine. This program is committed to increasing the diversity of the research workforce and strongly encourages applications from underrepresented, racial, and ethnic groups (UREGs). Read More.
|
|
|
|
|
Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)
National Institute of Dental and Craniofacial Research (NIDCR)
|
Notice of Special Interest (NOSI): Urgent Competitive Revisions and Administrative Supplements for Research at NIMHD Research Centers in Minority Institutions (RCMI U54s) on SARS-CoV-2 Vaccine Hesitancy, Uptake, and Implementation
National Institute on Minority Health and Health Disparities (NIMHD)
|
|
|
|
Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
National Center for Advancing Translational Sciences (NCATS)
|
Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control
National Cancer Institute (NCI)
|
|
|
|
Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
National Institute on Drug Abuse (NIDA)
|
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
|
|
|
|
|
Mapping Which Coronavirus Variants Will Resist Antibody Treatments
The variants, particularly one called B.1.351 that was first identified in South Africa, have raised growing concerns about the extent to which their mutations might help them evade current antibody treatments and highly effective vaccines. Read More
|
|
|
|
|
Clinical Trial in Hospitalized COVID-19 Patients Evaluates Long-Acting Antibody Therapy
An international randomized, controlled Phase 3 clinical trial has begun evaluating the safety and efficacy of an investigational long-acting antibody combination
for treating people hospitalized with COVID-19. Read More
|
|
|
|
|
NIDCD Grantees to Develop New Smell and Taste Tests to Screen for COVID-19 and Possible Future Viral Diseases
These projects focus on developing new tests that are cost-effective, stable, rapid, and readily scalable, allowing them to be used in any setting, including at home, at large venues, in schools, and in under-resourced communities. Read More
|
|
|
|
|
Lasting Immunity Found After
Recovery from COVID-19
After people recover from infection with
a virus, the immune system retains a memory of it. Immune cells and proteins that circulate in the body can recognize and kill the pathogen if it’s encountered again, protecting against disease and reducing illness severity. Read More
|
|
|
|
|
Intranasal Influenza Vaccine
Spurs Strong Immune Response in Phase 1 Study
The investigational vaccine, called
Ad4-H5-VTN, is a recombinant, replicating adenovirus vaccine designed to spur antibodies to hemagglutinin, a protein found on the surface of influenza viruses that attaches to human cells. Read More
|
|
|
|
|
Last Webinar Before Application Deadline for New NIH Challenge Prize
Feb. 11, 2021, 3 p.m.
|
|
|
|
|
Seminar Series on Data Sharing and Reuse
Feb. 12, 2021, 12 p.m.
|
The NIH Office of Data Science Strategy is hosting a new seminar series to highlight exemplars of data sharing and reuse. This series will feature exciting stories of researchers who have taken existing data and found clever ways to reuse the data or generate new findings. More Details Here. |
|
|
|
|
Bridging Patient Care Silos: Co-Locating Cross-Function Teams
Feb. 17, 2021, 12-1 p.m.
|
Boston Medical Center’s Dedicated Observation Unit uses co-located cross-functional teams. They are equipped to treat a wider variety of more severely sick patients than the typical observation unit and have a collocated cross-functional team structure. This enables the use of exclusion criteria—rather than the typical inclusion criteria—which enables the unit to efficiently treat patients. They also can take more patients, freeing up in-patient beds for others. In this talk, we discuss the impact of this approach on patient outcomes and length of stay. More Details Here
|
|
|
|
|
Research on Tap: Eliminating Health Disparities: Society & Biomedicine
Feb. 23, 2021, 2 - 3:30 p.m.
|
In four-minute talks, faculty representing a breadth of research from across Boston University will share ways in which they’re using cutting-edge research tools to study societal determinants of health, community engagement, and biomolecular sciences to adopt a more holistic approach to disease prevention and treatment. More Details Here.
|
Embracing Creativity & Discomfort in Pursuit of Impact
Feb. 25, 2021, 3 - 4:30 p.m.
|
Faculty innovators from across BU schools and colleges will share their diverse paths from invention to market to impact. The session will touch on the challenges and opportunities of navigating the world of business as an academic researcher, the importance of setting a personal objective and assessing market need, and the concepts of creativity and innovation in the context of translational research.
|
|
|
|
|
|
Accelerating Discoveries Towards Better Health
|
bu.edu/ctsi | ncats.nih.gov
|
|
|
|
|
|
|
